News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Melissa Fassbender
- Last updated on
At Invetech, David Kneen has been appointed as vice president, cell therapy.
Kneen has 11 years of experience with the company from two separate time periods.
Since returning to Invetech, he has managed cell therapy manufacturing automation programs for clients across the US and Europe.
Kneen said he sees three areas of strategic focus and opportunity for his new role:
“Invetech's continued delivery of commercial-scale manufacturing establishment solutions to the nascent cell therapy industry, leveraging our commercial manufacturing expertise to provide flexible yet robust development modules for clinical players, and exploring the potential for new industry partnerships."